cdi gmp bis 3 5 (InvivoGen)
InvivoGen is a verified supplier 
InvivoGen manufactures this product 
96
Structured Review
InvivoGen
cdi gmp bis 3 5
Cdi Gmp Bis 3 5, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclic+di+gmp/c-di-GMP/bio_rxiv__64898__2026__01__21__700774-223-18-23
Average 96 stars, based on 152 article reviews
Cdi Gmp Bis 3 5, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclic+di+gmp/c-di-GMP/bio_rxiv__64898__2026__01__21__700774-223-18-23
Average 96 stars, based on 152 article reviews
cdi gmp bis 3 5 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
other:Article Title: Nanoparticle constructs for systemic co-delivery of anti-tumor agents Article Snippet: MPLA (100 μg per 42 μmol lipid) was added prior to film formation (Sigma-Aldrich, St. Louis, MO). Article Title: DWL-4-140: A allene small molecule targeting STING that alleviates lupus-like phenotype in Trex1 -/- mice. Article Snippet: RAW264.7 cells (1.5 × 106 cells mL− 1), BJ cells (0.5 × 106 cells mL− 1), and MEFs (0.5 × 106 cells mL− 1) pretreated with DMSO were treated with DWL-4-140 (5 μM unless otherwise indicated) for 12 h, followed by stimulation with CMA (250 μg mL− 1, Sigma), DMXAA (20 μg mL− 1) for 2 h, HT DNA (2.5 μg mL− 1) for 6 h, or cyclic di-GMP or cGAMP (0.5 μg mL− 1, Biolog) for 4 h. Poly(I:C) (1.5 μg mL− 1) or Article Title: Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells. Article Snippet: The human CAR-expressing constructs were generated by fusing geneblock fragments (custom ordered from IDT) into a lentiviral vector containing the EF1a promoter. Article Title: Pharmacological inhibition of STING reduces neuroinflammation-mediated damage post-traumatic brain injury. Article Snippet: Xylazine (Cat. No. X1251), goat serum (Cat. No. G9023), Tween-20 (Cat. No. P1379), Triton X-100 (Cat. No. T8787), sodium dodecyl sulphate (SDS; Cat. No. L3771), sodium deoxycholate (Cat. No. D6750), ethylenediaminetetraacetic acid (EDTA; Cat. No. E9884), 2-mercaptoethanol (Cat. No. M3148), cOmplete protease inhibitor cocktail tablet (Cat. No. 11697498001), PhosSTOP phosphatase inhibitor cocktail tablet (Cat. No. 4906845001) and polyvinylidene fluoride (PVDF) membranes (Cat. No. IPVH00010) were purchased from Merck Life Science (VIC, AUS). Article Title: Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression Article Snippet: A single dose consisting of 10 μg of peptide (peptide stock is 10 mg/mL resuspended in DMSO) was added to 25 μg Article Title: Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR. Article Snippet: Adjuvant:Article Title: Acellular Pertussis Vaccines Induce CD8 + and CD4 + Regulatory T Cells That Suppress Protective Tissue‐Resident Memory CD4 + T Cells, in Part via IL‐10 Article Snippet: In prime‐boost studies, mice were immunized on days 0 and 28, by i.p. (200 μL/mouse), i.m. (50 μL/mouse) or i.n. route (25 μL/mouse) with 1/20th or 1/50th of the human dose of the primary hexavalent vaccine containing aP, Infanrix (GlaxoSmithKline), or 1/10 th of the human dose of the booster TdaP vaccine, Boostrix (GlaxoSmithKline). .. The adjuvant LP‐GMP was formulated with |